Riskpilot← Back to searchSign inGet full accessDANSK BIOSALG ApS
APSActiveCVR 36491493Tjørnevang 16Retail sale of other new goods · NACE 4778Est. 201513 employees
Revenue 2025
DKK 4,8M
+15% vs 2024
EBITDA margin
8.1%
+10% vs 2024
Equity ratio
13.6%
Financial strength
Net profit 2025
DKK 100K
+128% vs 2024
| Revenue | DKK 4,8M | +15% |
| EBITDA | DKK 387K | +10% |
| Net profit | DKK 100K | +128% |
| Total assets | DKK 4,9M | +7% |
| Equity | DKK 667K | +45% |
| Employees | 13 | — |
Legal name
DANSK BIOSALG ApS
CVR number
36491493
Legal form
Anpartsselskab
NACE code
4778 · Retail sale of other new goods
Founded
12. januar 2015
Share capital
DKK 50.000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er handel, transport og investeringsvirksomhed samt dermed beslægtet virksomhed.
Address
Tjørnevang 16
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3.101 | 4.129 | 4.096 | 4.151 | 4.756 |
| Staff expenses | -2.579 | -4.530 | -3.797 | -3.801 | -4.469 |
| EBITDA | 522 | -402 | 299 | 350 | 387 |
| Depreciation & amort. | -264 | -19 | -41 | -66 | -38 |
| EBIT | 258 | -421 | 259 | 284 | 349 |
| Net financials | -49 | -56 | -73 | -221 | -193 |
| Profit before tax | 209 | -477 | 185 | 64 | 156 |
| Tax | 58 | -94 | 54 | 20 | 56 |
| Net profit | 151 | -383 | 132 | 44 | 100 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4.507 | 4.381 | 4.493 | 4.587 | 4.904 |
| Equity | 1.115 | 404 | 535 | 461 | 667 |
| Long-term debt | 0 | 0 | 984 | 976 | 901 |
| Short-term debt | 3.362 | 3.978 | 2.973 | 3.151 | 3.293 |
| Total debt | 3.362 | 3.978 | 3.957 | 4.126 | 4.195 |
EBITDA margin
8.1%
This company
15.8%
Market median
-49% vs market
20212025
Equity ratio
13.6%
This company
38.2%
Market median
-64% vs market
20212025
Return on equity
15.0%
This company
18.4%
Market median
+18% vs market
20212025
Net profit margin
2.1%
This company
8.1%
Market median
-74% vs market
20212025
Asset turnover
0.97×
This company
1.12×
Market median
+13% vs market
20212025
Debt / equity
6.35×
This company
0.62×
Market median
-924% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HL Management | Management | 2015 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 90–99.99% | 90–99.99% | 2015 | |
| Individual | 5–9.99% | 5–9.99% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DBS HOLDING SORØ ApS
DANSK BIOSALG ApS Board members of DANSK BIOSALG ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Lars Eriksen | Management | 0 companies |